PL365136A1 - Preparat węglowodanowy (prebiotyczny adiuwant) dozwiększania odpowiedzi immunologicznej - Google Patents

Preparat węglowodanowy (prebiotyczny adiuwant) dozwiększania odpowiedzi immunologicznej

Info

Publication number
PL365136A1
PL365136A1 PL01365136A PL36513601A PL365136A1 PL 365136 A1 PL365136 A1 PL 365136A1 PL 01365136 A PL01365136 A PL 01365136A PL 36513601 A PL36513601 A PL 36513601A PL 365136 A1 PL365136 A1 PL 365136A1
Authority
PL
Poland
Prior art keywords
enhancement
immune response
carbohydrate formulation
prebiotic
adjuvant
Prior art date
Application number
PL01365136A
Other languages
English (en)
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of PL365136A1 publication Critical patent/PL365136A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
PL01365136A 2000-03-01 2001-02-14 Preparat węglowodanowy (prebiotyczny adiuwant) dozwiększania odpowiedzi immunologicznej PL365136A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
PL365136A1 true PL365136A1 (pl) 2004-12-27

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365136A PL365136A1 (pl) 2000-03-01 2001-02-14 Preparat węglowodanowy (prebiotyczny adiuwant) dozwiększania odpowiedzi immunologicznej

Country Status (21)

Country Link
US (2) US20030040492A1 (pl)
EP (1) EP1261355B1 (pl)
JP (1) JP4838477B2 (pl)
KR (1) KR20020081375A (pl)
CN (1) CN1243551C (pl)
AR (1) AR027968A1 (pl)
AT (1) ATE283697T1 (pl)
AU (2) AU2001231746C1 (pl)
BR (1) BR0108828A (pl)
CA (1) CA2400969C (pl)
DE (1) DE60107544T2 (pl)
ES (1) ES2232591T3 (pl)
HU (1) HUP0204546A3 (pl)
IL (1) IL151280A0 (pl)
MX (1) MXPA02008447A (pl)
NO (1) NO20024011D0 (pl)
PL (1) PL365136A1 (pl)
PT (1) PT1261355E (pl)
UA (1) UA73763C2 (pl)
WO (1) WO2001064225A1 (pl)
ZA (1) ZA200207849B (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008046625A2 (en) * 2006-10-18 2008-04-24 Dsm Ip Assets B.V. Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP2187756A1 (en) * 2007-08-24 2010-05-26 Barry Callebaut AG Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
WO2009151330A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
EP3342413B1 (en) 2009-07-15 2021-10-20 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing viral diarrhoea
MY189329A (en) 2009-07-15 2022-02-04 Nutricia Nv Mixture of non-digestible oligosaccharides for stimulating the immune system
CN102595934A (zh) * 2009-11-12 2012-07-18 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) * 2012-03-28 2015-03-26 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
WO2015065194A1 (en) 2013-11-04 2015-05-07 N.V. Nutricia Fermented formula with non digestible oligosaccharides
CN107921058B (zh) * 2015-08-04 2021-04-16 南方糖业股份公司 菊糖对鼻窦炎的预防作用
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
JP2020533291A (ja) * 2017-09-08 2020-11-19 エヴェロ バイオサイエンシズ，インコーポレーテッド プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞
CN111148531A (zh) 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN113876935B (zh) * 2021-10-19 2025-11-04 深圳市红瑞生物科技有限公司 一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725683B2 (ja) * 1985-10-31 1995-03-22 ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− 免疫治療方法
US5422346A (en) 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
EP0692252B1 (en) * 1994-06-14 2001-04-04 "Raffinerie Tirlemontoise", société anonyme: Use of a composition containing inulin or oligofructose in cancer treatment
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
CA2400969A1 (en) 2001-09-07
AR027968A1 (es) 2003-04-16
EP1261355A1 (en) 2002-12-04
EP1261355B1 (en) 2004-12-01
CN1422158A (zh) 2003-06-04
IL151280A0 (en) 2003-04-10
DE60107544D1 (de) 2005-01-05
ES2232591T3 (es) 2005-06-01
DE60107544T2 (de) 2005-12-15
HUP0204546A2 (en) 2003-05-28
NO20024011L (no) 2002-08-22
BR0108828A (pt) 2002-12-10
PT1261355E (pt) 2005-02-28
CN1243551C (zh) 2006-03-01
CA2400969C (en) 2011-04-19
HK1051650A1 (en) 2003-08-15
US7101553B2 (en) 2006-09-05
ATE283697T1 (de) 2004-12-15
NO20024011D0 (no) 2002-08-22
WO2001064225A1 (en) 2001-09-07
ZA200207849B (en) 2003-12-30
AU3174601A (en) 2001-09-12
MXPA02008447A (es) 2002-12-13
AU2001231746B2 (en) 2004-12-23
US20030040492A1 (en) 2003-02-27
UA73763C2 (en) 2005-09-15
JP4838477B2 (ja) 2011-12-14
JP2003533438A (ja) 2003-11-11
KR20020081375A (ko) 2002-10-26
AU2001231746C1 (en) 2005-10-06
HUP0204546A3 (en) 2003-10-28
US20040191234A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
IL151280A0 (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
IL218666A0 (en) Enhancement of antibody-medicated immune responses
HUP0200815A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
GB2361186B (en) Formulation for the prevention of cardiovascular disease
AU2001286653A1 (en) Manufacturing orthopedic parts using supercritical fluid processing
HUP0203972A3 (en) Composition of antigen and glycolipid adjuvant sublingual administration
GB2379741B (en) Method for reducing the effect of Sea-surface ghost reflections
EP1352980A4 (en) SILICON RICH STAINLESS STEEL
PT1265633E (pt) Adjuvante para vacinas
GB2364642B (en) Compositions for enhancing the immune response
GB2376797B (en) Stable oxide-free silicon surface preparation
PT1446107E (pt) Composições orais de libertação controlada compreendendo um composto de vitamina d e veículo ceroso
IL139832A0 (en) Therapeutic compositions that produce an immune response by altering the antigen
GB2390811B (en) Therapeutic compositions that alter the immune response
SI1187629T1 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
WO2002017961A1 (en) Vaccine preparation containing fatty acid as component
GB0114151D0 (en) Mounting structure of semiconductor packeage
IL139730A0 (en) Silicon capacitive accelerometer
AU6604701A (en) Method to induce the TH1 immune response
DK1261355T3 (da) Carbohydratformulering (præbiotisk adjuvans) til forstærkning af immunresponset
AU2002364161A8 (en) Enhancement of the immune response using cd36-binding domain
IL157823A0 (en) Preparation and isolation of indolocarbazole glycosides
AU2001266669A1 (en) Adjuvant preparation for the induction of specific immunity
AU2002358680A1 (en) Device for improving the rinse effect of dishwashers
AU2002326582A1 (en) Immune tolerance to predetermined antigens

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)